Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 85M | 153M | 105M | 101M |
Cost of revenue | -5M | 26M | -5M | -6M |
Gross profit | 90M | 127M | 110M | 107M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 42M | 55M | 34M | 31M |
Operating income | 3M | 26M | 33M | 33M |
Non operating interest income | ||||
Income | 5M | 11M | 10M | 10M |
Expense | 10M | 20M | 20M | 19M |
Other income expense | — | — | — | — |
Pretax income | -19M | 34M | 24M | 30M |
Tax provision | 0 | 1M | -38M | 0 |
Net income | -19M | 33M | 63M | 30M |
Basic EPS | -0.4 | 0.9 | 1.6 | 0.8 |
Diluted EPS | -0.4 | 0.9 | 1.6 | 0.8 |
Basic average shares | 41.3M | 41.4M | 41.5M | 42.2M |
Diluted average shares | 41.3M | 41.4M | 41.5M | 42.2M |
EBITDA | 14M | 78M | 66M | 69M |
Net income from continuing op. | — | — | — | — |
Minority interests | 3M | 3M | 2M | 2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |